Brief: Cellect Biotechnology, Washington University Finalize Accelerated Clinical Trial Agreement
08/07/2019 12:26
July 8 (Reuters) - Cellect Biotechnology Ltd APOP.O :
* CELLECT BIOTECHNOLOGY AND WASHINGTON UNIVERSITY (WU)
FINALIZE
ACCELERATED CLINICAL TRIAL AGREEMENT
* CELLECT BIOTECHNOLOGY LTD - APPROVAL OF SCIENTIFIC
ADVISORY
BOARD EXPECTED BY MID-Q3 OF 2019
* CELLECT BIOTECHNOLOGY LTD - EXPECTS TO SUBMIT IND
APPLICATION
WITH FDA BY END OF Q3 OF 2019
Source text for Eikon: ID:nPn6m9P3Va
Further company coverage: APOP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM